Edition:
India

Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

99.97USD
22 Jan 2018
Change (% chg)

$-0.59 (-0.59%)
Prev Close
$100.56
Open
$100.48
Day's High
$100.70
Day's Low
$99.67
Volume
668,181
Avg. Vol
629,028
52-wk High
$100.87
52-wk Low
$78.97

Latest Key Developments (Source: Significant Developments)

Danaher Sees FY 2018 Adjusted Earnings Per Share $4.25 To $4.35
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Danaher Corp ::DANAHER INITIATES 2018 OUTLOOK.SEES FY 2018 EARNINGS PER SHARE $3.50 TO $3.60.SEES FY 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $4.25 TO $4.35.FY2018 EARNINGS PER SHARE VIEW $4.34, REVENUE VIEW $19.09 BILLION -- THOMSON REUTERS I/B/E/S.- SEES 2018 NON-GAAP CORE REVENUE GROWTH BETWEEN 3.5 PERCENT AND 4 PERCENT.  Full Article

Danaher Announces Leadership Appointment
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Danaher Corp ::DANAHER ANNOUNCES LEADERSHIP APPOINTMENT.DANAHER CORP - ‍BOARD OF DIRECTORS IS APPOINTING JOAKIM WEIDEMANIS TO POSITION OF EXECUTIVE VICE PRESIDENT OF DANAHER CORPORATION​.DANAHER CORP - ‍WITH THIS APPOINTMENT, WEIDEMANIS WILL BECOME AN EXECUTIVE OFFICER OF COMPANY​.  Full Article

Quidel Says Confident In Validity Of Supply Agreement With Beckman Coulter To Sell BNP Assay Assets
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Quidel Corp ::QUIDEL CONFIDENT IN LEGAL STRENGTH AND VALIDITY OF SUPPLY AGREEMENT WITH BECKMAN COULTER TO SELL BNP ASSAY ASSETS.CO ‍ACKNOWLEDGED BECKMAN COULTER PLANS TO PURSUE COMMERCIAL LITIGATION TO ALLOW IT TO SELL BNP DIRECTLY.‍IN RECENT WEEKS, BOARD REJECTED OFFERS BY DANAHER CORP TO BUY BNP ASSAY BUSINESS​.‍BOARD FOUND THAT DANAHER'S PROPOSAL WAS "INADEQUATE" FOR BNP ASSAY BUSINESS​.  Full Article

IDBS says has been acquired by Danaher Corp
Monday, 30 Oct 2017 

Oct 30 (Reuters) - :U.K's IDBS says has been acquired by the life sciences platform of Danaher Corp.  Full Article

Danaher Q3 adjusted non-GAAP earnings per share $1.00
Thursday, 19 Oct 2017 

Oct 19 (Reuters) - Danaher Corp ::Danaher reports third quarter 2017 results.Sees Q4 2017 adjusted non-gaap earnings per share $1.12 to $1.16.Sees FY 2017 earnings per share $3.23 to $3.27.Sees Q4 2017 earnings per share $0.94 to $0.98.Q3 adjusted non-GAAP earnings per share $1.00.Q3 earnings per share $0.81.Q3 revenue $4.5 billion versus I/B/E/S view $4.47 billion.Q3 earnings per share view $0.95 -- Thomson Reuters I/B/E/S.Raises FY 2017 adjusted non-GAAP earnings per share view to $3.96 to $4.00.FY2017 earnings per share view $3.95 -- Thomson Reuters I/B/E/S.  Full Article

S&P places Danaher Corp. 'A' ratings on watch negative on planned acqusition of Cepheid
Tuesday, 6 Sep 2016 

S&P Global Ratings: S&P - Danaher Corp. 'A' ratings placed on watch negative on planned acqusition of Cepheid .S&P on Danaher - Timing of transaction, high acquisition multiple may manifest shift toward more aggressive financial policy than previously expected.  Full Article

Moody's says Danaher's A2 rating unaffected by planned acquisition of Cepheid
Tuesday, 6 Sep 2016 

Moody's:Moody's: Danaher's A2 rating unaffected by planned acquisition of Cepheid for $4 billion.  Full Article

Cepheid, Danaher merger deal termination fee set at $131 mln
Tuesday, 6 Sep 2016 

Cepheid :Cepheid will be required to pay Danaher termination fee of $131 million in certain circumstances, including if Cepheid terminates merger deal.  Full Article

Danaher to acquire Cepheid for $53.00 per share, or about $4 billion
Tuesday, 6 Sep 2016 

Danaher Corp : Danaher to acquire Cepheid for $53.00 per share, or approximately $4 billion . Says company expects acquisition to be approximately $0.30 accretive to non-gaap, adjusted diluted net earnings per share . Danaher expects to finance transaction with available cash and proceeds from issuance of debt . Estimates Cepheid acquisition will be about $0.05 accretive to non-gaap, adjusted diluted net earnings per share in first fy post acquisition . Acquisition has been unanimously approved by board of directors of each company .Says Cepheid will become part of Danaher's $5 billion diagnostics segment.  Full Article

Danaher Q2 adj non-GAAP EPS $1.25 from cont ops
Monday, 25 Jul 2016 

Danaher Corp : Both Q3 and full year 2016 guidance treat fortive as a discontinued operation for full year 2016. . Sees 2016 non-gaap adjusted diluted net earnings per share from continuing operations is expected to be $3.53 to $3.60 . Danaher reports second quarter 2016 results . Sees Q3 2016 GAAP earnings per share $0.47 to $0.51 from continuing operations . Sees FY 2016 gaap earnings per share $2.79 to $2.86 from continuing operations . Q2 adjusted non-GAAP earnings per share $1.25 from continuing operations . Q2 GAAP earnings per share $0.94 from continuing operations . Q2 earnings per share view $1.22 -- Thomson Reuters I/B/E/S . Sees FY 2016 adjusted non-gaap earnings per share $3.53 to $3.60 from continuing operations . Sees Q3 2016 adjusted non-gaap earnings per share $0.80 to $0.84 from continuing operations . Q2 revenue $5.8 billion versus I/B/E/S view $5.76 billion . Q3 earnings per share view $0.86, revenue view $4.12 billion -- Thomson Reuters I/B/E/S .FY 2016 earnings per share view $4.29, revenue view $19.72 billion -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Danaher Sees FY 2018 Adjusted Earnings Per Share $4.25 To $4.35

* SEES FY 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $4.25 TO $4.35